peripheral tissues. (a) Cells from the indicated tissues of the same mice that are shown in Fig. 6a and 6c were analyzed in parallel and the data are presented as in Fig. 6c. (b, c) Plotted is a fold difference of geometric means of the fluorescence intensities of each indicated marker (b) or B7.1 (c) on Ly5.1 + CD19 + iGB-4 or iGB-m cells, compared to those on the recipient-derived Ly5.1 -CD19 + B cells in spleen (b) or in spleen, lymph node and peripheral blood (c) of individual mice. Shown are collective
. Flow cytometric analysis for surface expression of BAFF-R or CCR7 on iGB cells. IgG1 + (red), IgM + (green) and IgE + (blue) populations in iGB cells 4 days after primary culture with IL-4 (iGB-4: day4), after the subsequent culture for 2 more days with IL-4 (iGB-4: day6) or with IL-21 (iGB-21: day6), or after 2 days' culture subsequent to the culture of iGB-21 (day6) with or without cytokines (iGB-m: day8) (see Fig. 5a ), and splenic naïve B cells from a C57BL/6 mouse (shaded), were stained with anti-IgG1-APC, anti-IgM-PE (Southern Biotech.), anti-IgE-FITC (Biolegend), anti-BAFF-R-biotin (P1B8), anti-CCR7-biotin (4B12: eBioscinece), streptavidin-PE/Cy7 (Biolegend), and analyzed by FACSCanto II on the same day. IgM + cells on day 6 and day 8 were very few and therefore omitted from the histograms. (a) Schematic representation of the cell transfer and immunization strategy. Three groups of C57BL/6 mice (5 per group) were injected i.v. with 1 x 10 7 CD4 + T cells (per mouse) purified from pooled spleens of 10 mice primed with CGG/alum 40 days before. Concomitantly, two groups were injected with 1.2 x 10 7 splenic B cells containing 5.3 x 10 4 NP + iMB cells (91 days after transfer) that are shown in Fig. 3g , and the other group with 1.2 x 10 7 naïve B cells from untreated C57BL/6 mice.
Twelve hours later, these mice were immunized i.v. with 25 µg NP 40 -CGG or CGG in PBS as indicated. (b, c) Anti-NP IgG1 serum titer was measured at the indicated days after immunization.
The mean value for each group is shown by a horizontal bar (b) and plotted in a linear graph with SD Figure S8 . Quantitative real-time PCR analysis for GC-related mRNAs in iGB cells. Quantitative real-time PCR analysis of GC-related transcripts in the following cells: splenic follicular B cells (Fo: CD43 -, CD138 -, CD19 + , CD23 high , CD21 + ) sorted from unimmunized C57BL/6 mice; physiological GC B cells (CD43 -, CD138 -, IgD -, CD19 + , Fas + , GL7 + ) sorted from C57BL/6 mice immunized with BSA/CFA 3 weeks before; iMB cells (Ly5.1 + , CD19 + , GL7 -, CD138 -) sorted from pooled spleens of recipient mice having been received Ly5.1 + iGB-4 cells 2 weeks earlier; plasmablastoid cells (PC: CD19 + , CD138 + ) sorted from iGB-21 cells; CD138 -IgG1 + (G1) or IgE + cells (E) sorted from iGB-4 or iGB-21 cells. Expression levels relative to that in follicular B cells (set as 1) are shown. The error bars indicate the SD of triplicate samples. Data shown are representative of two independent experiments. The following primer sets were used for the PCR: Irf-4 sense: 5'-ctaccccatgacagcacctt-3'; Irf-4 antisense: 5'-ccaaacgtcacaggacattg-3', Irf-8 sense: 5'-aggctgcatgagcgaagttc-3'; Irf-8 antisense: 5'-ccatgtactcatccacagaaggtt-3', Pax-5 sense: 5'-gtcatcggtgagcaccgactc-3'; Pax-5 antisense: 5'-gaagccatggctgaatactc-3', Bcl-6 sense: 5'-ctgcagatggagcatgttgt-3'; Bcl-6 antisense: 5'-tgtcctcacggtgccttttt-3', Bach2 sense: 5'-agttcatccacgacatcc-3'; Bach2 antisense: 3'-tgattcctctccgac-3', Blimp-1 sense: 5'-gaacctgcttttcaagtatgctg-3'; Blimp-1 antisense: 5'-agtgtagacttcaccgatgagg-3', Bcl-xL sense: 5'-taccggagagcgttcagtga-3'; Bcl-xL antisense: 5'-ccagtttactccatccccgaaag-3', Bcl-2 sense: 5'-gtggatgactgagtacc-3'; Bcl-2 antisense: 5'-acagccaggagaaatca-3'. Supplementary Table S1 . 
